Formulations of guanylate cyclase C agonists and methods of use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9616097
APP PUB NO 20120237593A1
SERIAL NO

13421769

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides low-dose formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAUSCH HEALTH IRELAND LIMITED3013 LAKE DRIVE CITYWEST BUSINESS CAMPUS DUBLIN 24

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Comiskey, Stephen Doylestown, US 22 129
Feng, Rong Langhorne, US 19 87
Foss, John Doylestown, US 24 220
Shailubhai, Kunwar Audubon, US 96 1112

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 11, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00